CRL
CRL
NYSE · Life Sciences Tools & Services

Charles River Laboratories

S&P 500 Mid-Cap Stocks Healthcare Stocks
$186.60
+5.04 (+2.78%)
As of Jun 23, 9:46 PM ET ·
Analyst Consensus
Buy
24
Analysts
High
Coverage
Buy 16 67%
Hold 8 33%
Sell 0 0%
Price Target
Analyst Price Target -61.8% upside
Low Target $57.45
Average Target $71.21
High Target $105.86
Current Price $186.60
Current
$186.60
Target
$71.21
$57.45 $71.21 avg $105.86
Scenario Analysis
Bear Case
$57.45
-69.2%
Low target
Base Case
$71.21
-61.8%
Avg target
Bull Case
$105.86
+-43.3%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$228.88
-18.5% from high
52-Week Low
$143.06
+30.4% from low
50-Day SMA
$200.46
-6.9% vs SMA
200-Day SMA
$169.92
+9.8% vs SMA
RSI (14)
21.1
Oversold
Target vs 52W High
$71.21
-68.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 34 85% $369.21 -21.3%
DHR
Danaher Corp
 Strong Buy 30 90% $158.11 -11.7%
A
Agilent Technologies Inc
 Strong Buy 28 79% $64.69 -48.9%
WAT
Waters Corp
 Buy 28 57% $189.60 -46.9%
IQV
Iqvia Holdings Inc
 Strong Buy 30 80% $82.96 -51.6%
ILMN
Illumina Inc
 Buy 28 61% $169.36 +2.7%
WST
West Pharmaceutical Services
 Strong Buy 22 82% $136.24 -59.5%
MTD
Mettler-Toledo International
 Hold 20 50% $170.43 -85.3%